Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423911
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-16
Brief Title:
Study of Olverembatinib HQP1351 in Patients With CP-CML
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-16
First Submit QC Date:
May 16 2024
Study First Post Date:
2024-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL